 Home > Active Ingredient News > Antitumor Therapy > NEJM: 177Lu-PSMA-617 targeted radiotherapy for the treatment of metastatic castration-resistant prostate cancer

NEJM: 177Lu-PSMA-617 targeted radiotherapy for the treatment of metastatic castration-resistant prostate cancer

 Last Update: 2021-09-29
 Source: Internet
 Author: User

Tags

american standard

merck cancer drug

6 4 soow

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Castration-resistant prostate cancer (CRPC) patients still progress after the initial continuous androgen deprivation treatment.

Recently, researchers evaluated the therapeutic effect of 177Lu-PSMA-617 on mCRPC patients

This study is an international, public, phase III trial.

immunity

A total of 831 patients participated in the study, and the baseline characteristics of the patients were similar

Compared with standard care, in the 177Lu-PSMA-617 group, imaging-based progression-free survival (median progression-free survival: 8.

Differences in progression-free survival and overall survival between groups

For patients with advanced PSMA-positive metastatic castration-resistant prostate cancer, 177Lu-PSMA-617 targeted radiotherapy can significantly improve the patient's progression-free survival rate and overall survival rate

For patients with advanced PSMA-positive metastatic castration-resistant prostate cancer, 177Lu-PSMA-617 targeted radiotherapy can significantly improve the patient’s progression-free survival rate and overall survival rate.

Original source:

Oliver Sartor et al.

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.